Stocktoria
NEXGEL, INC. NXGL
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-12-22
NEXGEL, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 39.5% | 31.6% | 9.1% | 12.5% | 0.5% |
| Operating margin | -29.3% | -40.9% | -85.0% | -163.5% | -165.7% |
| Net margin | -26.3% | -37.8% | -77.2% | -231.7% | -277.9% |
| FCF margin | -12.1% | -49.6% | -96.2% | -150.8% | -194.8% |
| Return on assets | -28.7% | -29.9% | -31.7% | -45.8% | -25.4% |
| Return on equity | -61.3% | -54.0% | -61.1% | -62.1% | -35.7% |
| Debt / equity | 0.12× | 0.11× | 0.11× | 0.04× | — |
| Current ratio | 1.47 | 2.07 | 1.98 | 8.74 | 4.82 |
| Revenue growth | 31.5% | 112.5% | 99.7% | 32.0% | 130.1% |
Source: SEC EDGAR filings · CIK 0001468929 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.